http://web.archive.org/web/20131130162559id_/http://www.dailymail.co.uk/health/article-2512295/Arthritis-drug-Sarilumab-slows-condition-improves-mobility.html

by @entity0 published : 06:55 est , 23 november 2013 @entity2 : 08:54 est , 23 november 2013 arthritis sufferers have been given new hope following the success of a drug that appears to ease the crippling symptoms of the disease			1
patients who took @entity11 were more mobile and suffered less inflammation to their joints , a study found			1
the new treatment - involving an injection once a fortnight - also slowed progression of the incurable disease			2
hope : patients who took @entity11 found they were more mobile and suffered less inflammation to their joints scientists carried out a year - long study on 1,200 patients with active , moderate - to - severe rheumatoid arthritis , who have not benefited from or been able to tolerate the side effects of current frontline treatment methotrexate			1
they found @entity25 improved their condition by up to 20 per cent , according to the @entity27			2
developed by @entity30 drugmaker @entity29 and @entity31 , the new drug works by blocking an inflammation - causing protein called interleukin 6			2
patients given a 200 mg dose of @entity25 every other week - on top of methotrexate - saw a 66 percent improvement in the symptoms of rheumatoid arthritis after six months			1
developers : the drug has been developed by @entity30 drugmaker @entity29 , above , in partnership with @entity31 meanwhile , those given a 150 mg dose saw a 58 percent improvement			0
reported side effects included infections , as well as increases in ' bad ' low - density lipoprotein ( @entity51 ) cholestoral and transaminases			0
last night , scientists , doctors and charities hailed the drug as a breakthrough in the fight against rheumetoid arthritis			2
a spokesman for the @entity61 ( @entity61 ) said : ' if this drug gives another option for those living with the disease to lead a fuller and more productive life then this can only be a positive development			0
' meanwhile , a spokesman for @entity70 said : ' the initial results from this trial look quite promising in terms of reducing painful symptoms - although @entity11 is still under development and results of this study have not yet been published			1
' more than 700,000 people in the @entity79 suffer the agonising effects of rheumatoid arthritis , in which the body 's immune system mistakenly attacks healthy tissue , causing inflammation and pain in the joints			1
although there is currently no cure , numerous treatments are used to alleviate sufferers ' pain			0
common treatments include anti-inflammatory painkillers and anti-rheumatic drugs , such as methotrexate , which are used to slow joint damage			0
the success of @entity25 pushes the new drug one step closer to the production line			0
it could be available in 10 years if it is officially approved .			0

@entity11 eases crippling symptoms of rheumatoid arthritis , a study found
patients were more mobile and suffered less inflammation to joints
treatment also slows down progression of the incurable condition

@entity31:Regeneron
@entity2:UPDATED
@entity0:Sophie Jane Evans
@entity27:Daily Express
@entity11:Sarilumab
@entity30:French
@entity25:Sarilumba
@entity51:LDL
@entity79:UK
@entity29:Sanofi
@entity70:Arthritis Research UK
@entity61:NRAS